Jump to navigation
Inspired by her work at an orphanage in Romania, Dr. Katalin Gothard aims to understand how the brain interprets the social, emotional and physical aspects of touch.
The Arizona CoVHORT study will answer questions about risk factors for severe COVID-19 infection and how the virus impacts long-term health.
A study led by Dr. Julie Bauman will be expanded to further investigate the safety and effectiveness of a personalized cancer vaccine.
UArizona researchers have developed a method of using ketamine in the treatment of Parkinson’s disease. The discovery has been licensed to Pharmather Inc. for development and commercialization.
Dr. Sairam Parthasarathy is one of 11 principal investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities.
Researchers have developed a rapid, simplified method for producing radio-labeling compounds used for PET scans.
A new diagnostic test for coronavirus relies on gargling with saltwater instead of using a nasal swab. Initial results have been encouraging, UArizona virology expert Michael Worobey says.
The gift from breast cancer survivor and longtime UArizona supporter Ginny Clements will strengthen patient care and research programs.
The contribution will allow UArizona researchers to continue developing better, more efficient and effective COVID-19 tests for people across the state.
UArizona researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity.